Skip to main content
. 2019 Mar 11;13(3):e0007246. doi: 10.1371/journal.pntd.0007246

Fig 2. ZIKV-specific NAbs titers (log10) among mothers of ZIKV laboratory-confirmed microcephaly cases, microcephaly cases and controls.

Fig 2

Microcephaly cases ZIKV laboratory-confirmed by qRT-PCR and/or ZIKV-specific IgM (n = 31), microcephaly cases with negative results by qRT-PCR and/or ZIKV-specific IgM (n = 58) and controls without microcephaly (n = 89).